http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CH-661930-A5

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bfc91c967e885ba5b44b7ad5278367f8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-0015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J7-0085
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J71-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J7-00
filingDate 1984-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_809aab0fd208ab21f92dc76740617a34
publicationDate 1987-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CH-661930-A5
titleOfInvention Process for the preparation of 17-esters of clobetasol
abstract The invention relates to an improved process for the preparation of 17-esters of clobetasol, which comprises treating 9ss,11ss-epoxy-16ss-methylpregna-1,4-diene-17,21-diol-3,20-dione 17-esters with mesyl chloride to give the corresponding 21-mesylate derivative, using lithium chloride for substituting the mesyloxy group to give the corresponding 21-chloro derivative, followed by opening of the epoxide group with hydrofluoric acid. The invention also relates to novel 17-esters of 21-chloro-9ss,11ss-epoxy-17-hydroxy-16ss-methylpregna-1,4-diene-3-20-dion es, which can be used as intermediates for the preparation of therapeutically active 9 alpha -halogeno-11ss-hydroxy derivatives as well as novel 17-esters of clobetasol. <IMAGE>
priorityDate 1983-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447708738
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID32798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21584144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66995
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID433294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415807307
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415735527
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22238436
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID101933
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413807575
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311051
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516572
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9782
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504692
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582418
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450422860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457280313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448748630

Total number of triples: 45.